Novartis CEO discusses how AI will impact drug development

Novartis Just Lost $12 Billion: So Why Is Nobody Getting Fired?

Novartis Stock CRASH ALERT! $12B Avidity Deal Fails, Drug Trial Disaster & Patent Cliff

Novartis ₹1,250 Crore Acquisition: Why Is The Pharma Giant Betting Big On Minipress XL?

How It Started Vs How Its going - Novartis | The Evolution of a Pharma Giant!

Novartis - History and Company profile (overview)

Novartis profit tops expectations

Have you ever wondered what a Novartis office looks like?

What HR professionals love about their jobs at Novartis

NOVARTIS JUST ENTERED THE DANGER ZONE

Novartis ‘focusing on high-end, innovative medicines,’ CEO says

Novartis not to move ahead with UK trial of anti-cholesterol drug Leqvio

Should You Buy Novartis THIS WEEK?! | #NVS Stock Analysis

Novartis Ruxolitinib Gets CDSCO Panel Nod For Acute And Chronic Graft Versus Host Disease

Novartis Careers, Slovenia - Apply today! #CuriousMindset

Novartis Has a Wide-ranging Pipeline Interview at Ophthalmology Innovation Summit @ ASCRS 2019

NOVARTIS: İSVİÇRE'NİN GİZEMİ #Novartis 🇨🇭

Group Lead, Clinical Project Management @Novartis, speaks on her journey to Leadership

Tackling Chagas Disease in Bolivia - a personal story

The HIDDEN History of Novartis! 🇨🇭 #Novartis

NEXT Talks - Speaking with Nikos Georgiades from Novartis

NOVARTIS AG: The 2026 INVESTOR DEEP DIVE – Patent Win, FDA Catalyst & 3.8% Dividend

India Remains A Strategic Market, Says Novartis India Chief

Need for Health Standardization in India | Saumil Modi, Novartis Oncology

Vasant Narasimhan Novartis CEO On Transforming Pharma Industry

Novartis Medicines and their Uses| Dr Ahmed Bukhari